Related Experiment Video
Updated: Jun 4, 2025
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease
Rania Chermiti1, Stéphane Burtey1,2, Laetitia Dou1
1C2VN, Aix-Marseille University, INSERM, INRAE, 13005 Marseille, France.
Insights
Chronic kidney disease (CKD) accelerates vascular inflammation, increasing cardiovascular disease (CVD) risk. Uremic toxins, especially from tryptophan, activate pathways like the aryl hydrocarbon receptor (AHR), driving inflammation and thrombosis in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular disease (CVD) is a significant complication in chronic kidney disease (CKD) patients.
- Vascular inflammation is a key driver of CVD pathogenesis and cardiovascular complications in CKD.
- CKD creates a pro-inflammatory milieu affecting the vascular wall, causing endothelial dysfunction and remodeling.
Purpose of the Study:
- To review the mechanisms by which CKD induces vascular inflammation.
- To examine the role of uremic toxins, particularly those from tryptophan metabolism, in CKD-associated vascular inflammation.
- To highlight the aryl hydrocarbon receptor (AHR) pathway in linking inflammation and thrombosis in CKD.
Main Methods:
- Literature review focusing on the pathogenesis of vascular inflammation in CKD.
- Analysis of mechanisms involving uremic toxins and their impact on vascular health.
- Examination of the interplay between inflammation, thrombosis, and the AHR pathway.
Main Results:
- CKD promotes vascular inflammation through accumulated uremic toxins.
- Tryptophan-derived uremic toxins and their interaction with the AHR are critical mediators.
- These processes contribute to endothelial dysfunction, oxidative stress, and vascular remodeling.
Conclusions:
- CKD-induced vascular inflammation is a primary mechanism for CVD development in these patients.
- Targeting uremic toxins and the AHR pathway may offer novel therapeutic strategies.
- Understanding these mechanisms can help reduce the cardiovascular burden in CKD.
Abstract:
Cardiovascular disease (CVD) is a major complication of chronic kidney disease (CKD), despite improvements in patient care. Vascular inflammation is a crucial process in the pathogenesis of CVD and a critical factor in the cardiovascular complications in CKD patients. CKD promotes a pro-inflammatory environment that impacts the vascular wall, leading to endothelial dysfunction, increased oxidative stress, and vascular remodeling. The uremic toxins that accumulate as kidney function declines are key contributors to vascular inflammatory processes. Our review will examine how CKD leads to vascular inflammation, paving the way to CVD. We will provide an overview of the mechanisms of vascular inflammation induced by uremic toxins, with a particular focus on those derived from tryptophan metabolism. These toxins, along with their receptor, the aryl hydrocarbon receptor (AHR), have emerged as key players linking inflammation and thrombosis. A deeper understanding of the mechanisms underlying inflammation in CKD, particularly those driven by uremic toxins, could reveal valuable therapeutic targets to alleviate the burden of CVD in CKD patients.
Related Concept Videos
01:10Nephrons
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:27Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:38Inflammation
01:22Heart Failure Drugs: Diuretics
01:16Antihypertensive Drugs: Action of Diuretics